INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.50, sa.2, ss.247-255, 2018 (SCI İndekslerine Giren Dergi)
Renal cell carcinoma (RCC) accounts for approximately 80% of the primary renal cancers, and current treatment strategies are not sufficient to provide a certain solution. Since there are not many treatment options, interest in discovery of alternative drugs has increased.